HomeOptio company news

Optio company news

  • JP Morgan Healthcare Conference, January 2019; Optio Biopharma Solutions conducts neurodegenerative rare disease asset valuation due diligence and other activities

    • January 15, 2019
    • Posted by: eric
    • Categories: Optio company news, Uncategorized
    No Comments
    read more

  • Optio welcomes Ebo Dawson-Andoh; Executive Consultant, Pharma/Healthcare Survey Analyst – January 2018

    • January 15, 2018
    • Posted by: admin
    • Categories: Optio company news, Uncategorized
    No Comments
    read more

  • Optio conducts social worker and caregiver focus group research at a neurological rare disease meeting – Chicago, IL.

    • June 21, 2017
    • Posted by: admin
    • Categories: Optio company news, Rare Disease Markets
    No Comments
    read more

  • Optio conducts business development interviews for a rare disease product valuation in conjunction with the 35th Annual J.P. Morgan Healthcare Conference.

    • January 9, 2017
    • Posted by: admin
    • Categories: Market Research NPP, Optio company news
    No Comments
    read more

  • Optio Biopharma Solutions attends the 23rd Annual Huntington’s Study Group Meeting and 10th Annual Clinical Research Symposium in Nashville, TN.

    • November 2, 2016
    • Posted by: admin
    • Categories: Marketing Project Management, Optio company news
    No Comments
    read more
  • 1
  • 2